|  |
Application process |
| Applicants are advised to submit a Concept Sheet for review by the Head of Clinical Development at Linde Gas Therapeutics, prior to undertaking a full application. A concept sheet may be submitted at any time and should include an overview of the project, the relevance of the project to the objectives of the Inspire Award and an estimated budget. The application will be a two phase process.
First phase
All concept sheets will be reviewed and evaluations of merit will be returned to the principal investigator within 6 weeks of receipt. Letters should be sent to
Linde Gas Therapeutics
Head of Clinical Development
The Priestley Centre
10, Priestley Rd
The Surrey Research Park
Guildford, Surrey GU27XY
Great Britain
or by email to inspireaward@linde.com
Second phase
Where a concept sheet is judged to pass the first screen, applicants will then be invited to undertake a full application, using the forms provided. This will include submission of a full research protocol, research plan and supplementary documents to Linde Gas Therapeutics for review by the Inspire Award Board.
All successful projects will be required to submit evidence of capability to conduct the research to the International Conference Harmonisation (ICH) Good Clinical Practice Guidelines, or the equivalent guideline for laboratory or engineering research and development.
Only applications written in English will be accepted.
Mail or email applications will be accepted.
In addition to being used for evaluating applications, the face page and the abstraction of the research plan may be used by Linde Gas Therapeutics for promotional purposes and for classification and programme analysis purposes.
|
|
| |
| |
|
